Weight Maintenance After Injectable Orforglipron ATTAIN-MAINTAIN demonstrated that patients switching from injectable tirzepatide or semaglutide to orforglipron maintained their weight loss, validating oral step-down therapy
They found that people taking GLP-1s were less likely to have anemia, blood clots in veins, low levels of white blood cells called neutrophils, low blood platelet count, sepsis, nausea and vomiting, fatigue, cardiomyopathy, and neuropathy after chemotherapy
Mice received water and diet (CRF-1
Your journey to a transformed body, mind, and energy starts now
At BODYWELLE, I use individualized treatment planning and careful follow-up to help patients manage side effects with appropriate, currently available weight management options
Here is a side-by-side look: Fixing Loose Skin and Ozempic Face Fast weight loss can leave marks